MedPath

A clinical trial to study the safety and efficacy of combination drug, vancomycin and ceftriaxone compared to vancomycin in mild to severe bacterial infections

Phase 3
Conditions
Mild to severe Bacterial infections( in Lower Respiratory Tract infection, Endocarditis, Skin infection, Meningitis, Bone infection.)
Registration Number
CTRI/2008/091/000060
Lead Sponsor
Venus Remedies Limited
Brief Summary

This is a open-labeled,double arm, randomized,multi-centric, trial TO EVALUATE THE SAFETY AND EFFICACY OF FIXED DOSE COMBINATION OF CEFTRIAXONE AND VANCOMYCIN INJECTION Vs. VANCOMYCIN INJECTION IN SUBJECTS WITH VARIOUS BACTERIAL INFECTIONS with 200 patients for 6 months that will be conducted in five centres in India.

Detailed Description

Not available

Recruitment & Eligibility

Sex
Not specified
Target Recruitment
200
Inclusion Criteria
  • All subjects aged between 18 and 70 years.Diagnosed subjects of infectious disease (on clinical evaluation).
  • Subjects willing to give informed consent.Subject suffering from any of the following infections- Lower respiratory tract infections, skin and skin structure infections, endocarditic, bacterial meningitis and bone infection.
Exclusion Criteria
  • History of hypersensitivity reaction or any specific contraindication to penicillin group of drugs or Ceftriaxone or Vancomycin.
  • Presence of hepatic or renal disorderPregnancy&/or lactationAlcoholics.

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
compare the efficacy of a 3.0g FDC of Ceftriaxone and Vancomycin Injection Vs. 1.0g Vancomycin Injection in subjects with Mild to Severe Bacterial infections.
Secondary Outcome Measures
NameTimeMethod
evaluate the safety of the test and comparative product

Trial Locations

Locations (5)

AIIMS

🇮🇳

Delhi, DELHI, India

Dr. Hedgewar Arogya Sansthan

🇮🇳

Delhi, DELHI, India

Kempegowda Institute of Medical Sciences

🇮🇳

Bangalore, KARNATAKA, India

Lokmanya Tilak Medical College

🇮🇳

Mumbai, MAHARASHTRA, India

S.P. Medical College

🇮🇳

Bikaner, RAJASTHAN, India

AIIMS
🇮🇳Delhi, DELHI, India
Dr. Namit Saraf
Principal investigator
09891290198
drnamitsaraf@rediffmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.